Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.59B | $6.02B | $7.17B | $6.06B | $6.02B | $5.87B | $6.44B | $5.49B |
| Cost of revenue | $2.09B | $2.21B | $2.54B | $2.21B | $2.18B | $2.12B | $2.26B | $1.98B |
| Gross profit | $4.50B | $3.81B | $4.63B | $3.85B | $3.84B | $3.74B | $4.17B | $3.52B |
| Gross margin | 68.3% | 63.3% | 64.5% | 63.6% | 63.8% | 63.8% | 64.9% | 64.0% |
| Research and development | $434.00M | $413.00M | $401.00M | $410.00M | $407.00M | $405.00M | $358.00M | $377.00M |
| Selling, general and administrative | $2.23B | $2.28B | $2.23B | $2.05B | $2.08B | $2.30B | $2.12B | $1.89B |
| Operating expenses | $2.84B | $2.87B | $2.82B | $2.72B | $2.73B | $2.91B | $3.59B | $2.43B |
| Operating income | $1.66B | $936.00M | $1.80B | $1.14B | $1.11B | $837.00M | $581.00M | $1.09B |
| Operating margin | 25.2% | 15.5% | 25.2% | 18.7% | 18.5% | 14.3% | 9.0% | 19.7% |
| EBITDA | $1.96B | $1.24B | $2.13B | $1.52B | $1.46B | $1.14B | $1.80B | $1.36B |
| Interest expense | −$141.00M | −$148.00M | −$607.00M | — | −$159.00M | −$137.00M | −$409.00M | — |
| Income before taxes | $1.56B | $850.00M | $1.71B | $1.03B | $1.02B | $764.00M | $528.00M | $1.04B |
| Income taxes | $288.00M | $105.00M | $856.00M | $170.00M | $132.00M | $110.00M | −$18.00M | $209.00M |
| Net income | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | $654.00M | $546.00M | $834.00M |
| Net margin | 19.4% | 12.4% | 11.8% | 14.2% | 14.7% | 11.1% | 8.5% | 15.2% |
| EPS, basic | $3.32 | $1.95 | $2.22 | $2.25 | $2.32 | $1.71 | $1.43 | $2.18 |
| EPS, diluted | $3.30 | $1.93 | $2.20 | $2.22 | $2.29 | $1.69 | $1.41 | $2.16 |
| Diluted shares | 386.00M | 386.50M | 386.50M | 386.70M | 386.40M | 386.40M | 386.30M | 385.60M |
Figures describe Stryker shares, not any token. As of Jul 31, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.